Literature DB >> 24661277

The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.

M K Sunwoo1, S Jeon, J H Ham, J Y Hong, J E Lee, J-M Lee, Y H Sohn, P H Lee.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate whether white matter hyperintensities (WMHs) may act as an independent predictor for progression of cognitive status, the authors analyzed the longitudinal effects of WMHs on cognitive dysfunction in non-demented patients with Parkinson's disease (PD).
METHODS: A total of 111 patients with PD were enrolled, including subjects with mild cognitive impairment (MCI, n = 65) and cognitively normal subjects (CN, n = 46). These individuals were classified as MCI converters (n = 22) or MCI non-converters (n = 43) and CN converters (n = 18) or CN non-converters (n = 28) based on whether they were subsequently diagnosed with PD dementia or PD-MCI during a minimum 24-month follow-up. The WMH burden and the Cholinergic Pathway Hyperintensities Scale (CHIPS) and their relationships to longitudinal changes in cognitive performance were examined.
RESULTS: PD-MCI converters had larger WMH volume (14421.0 vs. 5180.4, P < 0.001) and higher CHIPS score (22.6 vs. 11.2, P = 0.001) compared with PD-MCI non-converters. Logistic regression analysis revealed in patients with PD-MCI that WMH volume (odds ratio 1.616, P = 0.009) and CHIPS score (odds ratio 1.084, P = 0.007) were independently associated with PD dementia conversion. However, WMH volume and CHIPS score did not differ between PD-CN converters and PD-CN non-converters. In patients with PD-MCI, both WMH volume and CHIPS score were closely associated with longitudinal decline in general cognition, semantic fluency and Stroop test scores.
CONCLUSIONS: The present study demonstrates that WMH burden is a significant predictor of conversion from PD-MCI to PD dementia and is related to ongoing decline in frontal-lobe-based cognitive performance.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  Parkinson's disease; dementia converters; white matter hyperintensities

Mesh:

Year:  2014        PMID: 24661277     DOI: 10.1111/ene.12412

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

1.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

2.  Neuropsychological impact of white matter hyperintensities in older adults without dementia.

Authors:  Rihin Chavda; Jeffrey S Cao; Jared F Benge
Journal:  Appl Neuropsychol Adult       Date:  2019-07-09       Impact factor: 2.248

3.  White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.

Authors:  Ivan Rektor; Alena Svátková; Lubomir Vojtíšek; Iva Zikmundová; Jirí Vaníček; András Király; Nikoletta Szabó
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

4.  A structural MRI study of cholinergic pathways and cognition in multiple sclerosis.

Authors:  Yukio Kimura; Noriko Sato; Miho Ota; Norihide Maikusa; Tomoko Maekawa; Daichi Sone; Mikako Enokizono; Atsuhiko Sugiyama; Etsuko Imabayashi; Hiroshi Matsuda; Tomoko Okamoto; Takashi Yamamura; Hideharu Sugimoto
Journal:  eNeurologicalSci       Date:  2017-07-01

5.  Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Ozioma Okonkwo; Stephanie Krislov; Amy Barzgari; Frances Theisen; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Catherine L Gallagher
Journal:  Neuroimage Clin       Date:  2019-05-23       Impact factor: 4.881

6.  Orthostatic hypotension and dementia incidence: links and implications.

Authors:  Andrew D Robertson; Sean J Udow; Alberto J Espay; Aristide Merola; Richard Camicioli; Anthony E Lang; Mario Masellis
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-02       Impact factor: 2.570

7.  Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study.

Authors:  Han Zhu; Hao Lu; Fei Wang; Shuai Liu; Zhihong Shi; Jinghuan Gan; Xiaoshan Du; Yaqi Yang; Daibin Li; Lichen Wang; Yong Ji
Journal:  Front Neurol       Date:  2022-01-11       Impact factor: 4.003

8.  Frontal-subcortical defects correlate with task switching deficits in Parkinson`s disease.

Authors:  Amara Gul; Javed Yousaf; Hira Ahmad
Journal:  Neurosciences (Riyadh)       Date:  2017-07       Impact factor: 0.906

9.  White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Authors:  Mahsa Dadar; Yashar Zeighami; Yvonne Yau; Seyed-Mohammad Fereshtehnejad; Josefina Maranzano; Ronald B Postuma; Alain Dagher; D Louis Collins
Journal:  Neuroimage Clin       Date:  2018-09-27       Impact factor: 4.881

10.  Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.

Authors:  Alessandra Nicoletti; Antonina Luca; Roberta Baschi; Calogero Edoardo Cicero; Giovanni Mostile; Marco Davì; Giuseppe La Bianca; Vincenzo Restivo; Mario Zappia; Roberto Monastero
Journal:  J Neurol       Date:  2020-08-31       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.